Overview

Levosimendan Compassionate Use in Pediatric Patients With Advanced Decompensated Heart Failure

Status:
No longer available
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Open label study of levosimendan; planned comparison for effectiveness and safety to historic matched case controls from participating sites.
Details
Lead Sponsor:
Tenax Therapeutics, Inc.
Treatments:
Simendan